SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS

被引：22
|
作者：
Rutter, K. [1 ]
Ferlitsch, A. [1 ]
Maieron, A. [2 ]
Staettermayer, A. F. [1 ]
Graziadei, I. [3 ]
Dulic, M. [4 ]
Gschwantler, M. [4 ]
Stauber, R. [5 ]
Hofer, H. [1 ]
Peck-Radosavljevic, M. [1 ]
Vogel, W. [3 ]
Trauner, M. [1 ]
Ferenci, P. [1 ]
机构：
[1] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria
[2] Hosp Elisabethinen, Linz, Austria
[3] Med Univ Innsbruck, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria
[4] Wilhelminenspital Stadt Wien, Dept Internal Med 4, Vienna, Austria
[5] Med Univ Graz, Dept Gastroenterol & Hepatol, Graz, Austria
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60067-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
65
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
    Chen, Emerson Y.
    Sclair, Seth N.
    Czul, Frank
    Apica, Betty
    Dubin, Perry
    Martin, Paul
    Lee, William M.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 1014 - +
  • [2] Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study
    Verna, Elizabeth C.
    Saxena, Varun
    Burton, James R.
    O'Leary, Jacqueline G.
    Dodge, Jennifer L.
    Stravitz, Richard T.
    Levitsky, Josh
    Trotter, James F.
    Everson, Gregory T.
    Brown, Robert S., Jr.
    Terrault, Norah A.
    [J]. TRANSPLANTATION, 2015, 99 (08) : 1644 - 1651
  • [3] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [4] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    [J]. HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [5] Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c
    Garcia-Queiruga, Marta
    Purificacion, Cid
    Laura Maria, Martinez-Lopez
    Marta, Leston
    Luis, Margusino
    Isabel, Martin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 281
  • [6] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    [J]. HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [7] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    [J]. HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [8] Safety of triple therapy with Telaprevir hemophiliacs with hepatitis C
    Ioannidou, Panagiota
    Kouramba, Anna
    Adraktas, Theophanis
    Mandraki, Maria
    Olga, Katsarou
    [J]. HAEMOPHILIA, 2014, 20 : 39 - 40
  • [9] The safety and tolerability of telaprevir and boceprevir based triple therapy for hepatitis C genotype 1 in an Irish patient cohort
    El-Sherif, O.
    Quinn, C.
    Hynes, B.
    McGrath, M.
    Irish, H.
    McKiernan, S.
    Norris, S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S54 - S55
  • [10] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    [J]. HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
12345